go to home page team portfolio news contact

 

We're a venture capital firm specializing in life sciences. Since our launch in 2001, we’ve supported more than 20 young companies. We invest in traditional healthcare opportunities as well as emerging areas — such as nutrition, wellness, and green technology — in which we’ve built one of the largest portfolios in the country. We also have keen interest in platforms and tools that enable all of life science.

Our firm was created by people with both investment know-how and direct experience in getting new ventures off the ground. We use this expertise to invest in what we know best: exceptional opportunities in their early stages. And then we take an active, ongoing role in helping entrepreneurs develop the right strategy, team, and connections to succeed.
 

 

Recent News Releases  
           
  05 01 08  > Asoyia secures $4M of venture capital funding to expand its ultra low linolenic soybean products
03 06 08  > Singulex collaborates with Novartis Pharma AG utilizing Erenna Technology Access Program
01 30 08  > Attune Foods debuts two new probiotic wellness bars
01 29 08  > Indianapolis-based cancer researchers, C-S Keys, close on $6.25M of Series A financing
01 22 08  > Clinicians share initial positive experiences with Stereotaxis' new magnetic irrigated catheter
01 03 08  > Corazonas launches first and only cholesterol-reducing potato chips
           
 

Quick Notes

 

Recent Media Coverage

 
           


Attune
Wellness bar
mentioned in TIME as
part of the growing
probiotics trend

 
Kereos
Featured on Forbes.com
for its novel approach
to detecting cancer
with nanotechnology

 
Prolog
Christine Karslake
will speak on the
“Successful Corporate-
VC Partnerships” panel
at the World's Best
Technology Showcase

 
Prolog
Brian Clevinger
spoke on a panel
at Planting Seeds for
Collaboration in
Plant Sciences

 
The Natural Dentist
Oral rinse noted in
O, The Oprah Magazine
as the best
“Breath Fix”

 
Prolog
Dan Broderick spoke
on a VC panel
at the Private Equity
Conference at
Dartmouth

 
Corazonas
Heart-healthy chips
featured on "Good
Morning America" and
"Rachael Ray"

 

post masthead
 
Research suggests that APT Therapeutics' experimental drug helps block blood platelets from aiding cancer cells
March 08    Complete Article >
     

post masthead
 
Singulex' Erenna system used by Washington University in St. Louis to aid disease research
11 16 07    Complete Article >
     


 
Prolog discusses its experience with
health and wellness investing
October 07    Complete Article >
   


  Prolog's directors
combine their
multiple skills to
help their St. Louis
life science ventures
flourish
September 07
Complete Article >
     

  LightFull and Prolog interviewed in
“Perfect Match,”
an article on CEO/VC relationships
July 07
Complete Article >
     
 

post masthead
 
Monsanto, Divergence crack genetic code
of soybean pest
03 07 08    Complete Article >
     

american venture
  Prolog offers advice
for entrepreneurs
seeking capital
October 07
Complete Article >
     


  Prolog discusses the
merits of investing
in the health and
wellness space
September 07
Complete Article >
     


  Corazonas Foods
and LightFull Foods receive high rankings within “25 Best New Foods for You”
cover story
July 07
Article Excerpts >
     

ceo cover
  Prolog interviewed in
“The Enabler,”
an article on Prolog’s investments in
St. Louis’ life science ventures
July 07
Complete Article >
     
     
   

T O P